PreDxion Bio
closedPreDxion Bio aims to revolutionize critical care medicine by providing ICU doctors with actionable patient immune function data.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD39—58m (Dealroom.co estimates Sep 2020.)
San Francisco California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Grant | ||
N/A | Seed | ||
| N/A | $6.3m | Seed | |
| Total Funding | AUD9.7m | ||
Recent News about PreDxion Bio
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.